Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Biondi

Showing results (181-190 of 200) with videos related to

Pageof 20
Sort By:
Cephalalgia : an International Journal of Headache|September 9, 2009
Utility of topiramate for the treatment of patients with chronic migraine in the presence or absence of acute medication overuseH-C Diener, D W Dodick, P J Goadsby, et al.
Plos Computational Biology|December 12, 2018
Predicting protein targets for drug-like compounds using transcriptomicsNicolas A Pabon, Yan Xia, Samuel K Estabrooks, et al.
The EMBO Journal|November 18, 2006
Allosteric activation of the protein kinase PDK1 with low molecular weight compoundsMatthias Engel, Valerie Hindie, Laura A Lopez-Garcia, et al.
Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)|August 16, 2016
Water/cortical bone decomposition: A new approach in dual energy CT imaging for bone marrow oedema detection. A feasibility studyM Biondi, E Vanzi, G De Otto, et al.
ACS Chemical Biology|January 4, 2017
An Allosteric Inhibitor Scaffold Targeting the PIF-Pocket of Atypical Protein Kinase C IsoformsJose M Arencibia, Wolfgang Fröhner, Magdalena Krupa, et al.
Biochemical Pharmacology|October 17, 2017
Camptothecin and its analog SN-38, the active metabolite of irinotecan, inhibit binding of the transcriptional regulator and oncoprotein FUBP1 to its DNA target sequence FUSESabrina Khageh Hosseini, Stefanie Kolterer, Marlene Steiner, et al.
Allergy|January 1, 1996
Tilarin in combination with astemizoleD A Bukstein, R M Biondi, M M Blumenthal, et al.
Chemistry & Biology|November 29, 2011
Allosteric regulation of protein kinase PKCζ by the N-terminal C1 domain and small compounds to the PIF-pocketLaura A Lopez-Garcia, Jörg O Schulze, Wolfgang Fröhner, et al.
Journal of Medicinal Chemistry|March 26, 2021
Demonstrating Ligandability of the LC3A and LC3B Adapter InterfaceMarkus Hartmann, Jessica Huber, Jan S Kramer, et al.
Biochemical Pharmacology|February 12, 2014
Characterization of pomiferin triacetate as a novel mTOR and translation inhibitorMagdalena M Bajer, Michael M Kunze, Johanna S Blees, et al.
Pageof 20

Showing results (181-190 of 200) with videos related to

Sort By:
Pageof 20
Cephalalgia : an International Journal of Headache|September 9, 2009
Utility of topiramate for the treatment of patients with chronic migraine in the presence or absence of acute medication overuseH-C Diener, D W Dodick, P J Goadsby, et al.
Plos Computational Biology|December 12, 2018
Predicting protein targets for drug-like compounds using transcriptomicsNicolas A Pabon, Yan Xia, Samuel K Estabrooks, et al.
The EMBO Journal|November 18, 2006
Allosteric activation of the protein kinase PDK1 with low molecular weight compoundsMatthias Engel, Valerie Hindie, Laura A Lopez-Garcia, et al.
Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)|August 16, 2016
Water/cortical bone decomposition: A new approach in dual energy CT imaging for bone marrow oedema detection. A feasibility studyM Biondi, E Vanzi, G De Otto, et al.
ACS Chemical Biology|January 4, 2017
An Allosteric Inhibitor Scaffold Targeting the PIF-Pocket of Atypical Protein Kinase C IsoformsJose M Arencibia, Wolfgang Fröhner, Magdalena Krupa, et al.
Biochemical Pharmacology|October 17, 2017
Camptothecin and its analog SN-38, the active metabolite of irinotecan, inhibit binding of the transcriptional regulator and oncoprotein FUBP1 to its DNA target sequence FUSESabrina Khageh Hosseini, Stefanie Kolterer, Marlene Steiner, et al.
Allergy|January 1, 1996
Tilarin in combination with astemizoleD A Bukstein, R M Biondi, M M Blumenthal, et al.
Chemistry & Biology|November 29, 2011
Allosteric regulation of protein kinase PKCζ by the N-terminal C1 domain and small compounds to the PIF-pocketLaura A Lopez-Garcia, Jörg O Schulze, Wolfgang Fröhner, et al.
Journal of Medicinal Chemistry|March 26, 2021
Demonstrating Ligandability of the LC3A and LC3B Adapter InterfaceMarkus Hartmann, Jessica Huber, Jan S Kramer, et al.
Biochemical Pharmacology|February 12, 2014
Characterization of pomiferin triacetate as a novel mTOR and translation inhibitorMagdalena M Bajer, Michael M Kunze, Johanna S Blees, et al.
Pageof 20